RarePipelinepeopleInnovationCollaborationCareersFinance Advance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Hands typing on keyboard



Our latest press releases


News and insights

Meetings of interest

Impactful interaction with the scientific and medical community

At Hansa, we are focused on the bigger picture and want help rare disease patients live long and healthy lives. We do this also by constant engagement with the scientific and healthcare communities. We use this opportunity to not only raise awareness about the unmet needs of the patients, but also to help advance the understanding in these complex fields. Meetings of interest
Coffee and notepad


Sign up to receive updates on the latest company news and filings

Choose type

I consent to Hansa Biopharma handling my personal data. See our Privacy Policy for information about how we handle personal data.

Thank you. You will get an e-mail message to activate your subscription.